FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

CAPI 3 HEMOGLOBIN(E)

K Number: K180762 · Decision Dec 14, 2018
Classifications
1
FEI Numbers
10
Registration Numbers
10
Same Product Code
22
Applicant Total
32
Review Days
266

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
CAPI 3 HEMOGLOBIN(E)
K Number
K180762
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
864.7415
Medical Specialty
Hematology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Sebia
Date Received
March 23, 2018
Decision Date
December 14, 2018
Product Code
GKA
Advisory Committee
Hematology
Review Advisory Committee
HE
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
GKA Abnormal Hemoglobin Quantitation

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (GKA), ordered by most recent decision date.

View all

Other Clearances by Sebia

K Number Device Name
K232027 CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument
K231601 FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2
K210623 FLC Kappa, FLC Lambda, FLC Control Level 1, FLC Control Level 2
K203184 HYDRASHIFT 2/4 isatuximab
K192095 CAPI 3 Immunotyping, Capillarys 3 Tera
K190851 HYDRASHIFT 2/4 daratumumab
K171861 CAPILLARYS Hb A1c
K172195 HYDRASHIFT 2/4 daratumumab, daratumumab Control
K171537 CAPI 3 Hb A1c
K162281 CAPI 3 Hb A1c, MULTI-SYSTEM Hb A1C CAPILLARY CONTROLS (2)
Search all 32 clearances from Sebia →